Dendreon (DNDN) Sees Action on Renewed Takeover Speculation

March 21, 2012 11:23 AM EDT Send to a Friend
They're back...

That is takeover rumors on Provenge maker Dendreon (Nasdaq: DNDN).

Today's rumors are vague and come from what would seem to be unreliable sources. Nonetheless, the chatter is enough to move the stock 1.2 percent higher on the session.

The company's new CEO hire John Johnson brings with him an M&A background, having sold ImClone to Eli Lilly in the past, so takeover talk sprouts up quickly and frequently on the name.

In the recent past, Amgen (Nasdaq: AMGN) has been mentioned as a possible suitor.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Rumors

Add Your Comment